What caused the intraday move in IHL.AX stock today?

The intraday drop to A$0.041 and heavy **61,360,016** volume reflect low market cap liquidity, trader flow and sensitivity to clinical or corporate headlines. Small-cap healthcare names like IHL.AX often move sharply on execution updates or speculative trading.

What are the key financial risks for Incannex (IHL.AX)?

Major risks include continued negative EPS (**-1.30**), cash burn from R&D, potential dilution, and dependence on clinical trial outcomes. The company has strong current ratio **9.02**, but operating cash flow per share is negative.

What price target does Meyka AI model give for IHL.AX stock?

Meyka AI's forecast model projects a near-term price target of **A$0.080**, implying roughly **95.12%** upside versus the current price **AUD 0.041**. Forecasts are model-based projections and not guarantees.

How should traders approach IHL.AX given today’s volume spike?

Treat IHL.AX as high-volatility and use tight risk controls: trade small sizes, follow VWAP, set stop-losses and monitor newsflow related to trials or corporate announcements. Thin liquidity can create rapid price swings.

AU Stocks

IHL.AX Incannex Healthcare (ASX) A$0.041 -10.87% intraday Mar 2026: high volume

ByHuzaifa Zahoor March 3, 2026March 3, 2026

IHL.AX stock dropped to A$0.041 intraday on 03 Mar 2026, down -10.87%, as 61,360,016 shares traded by mid-session. The move makes Incannex Healthcare Limited (IHL.AX) one of the ASX’s most active names today, with a relative volume near 9.55 and a day range between A$0.041 and A$0.051. Traders are reacting to thin market capitalisation of A$14,255,927, a low 50-day average price of A$0.065, and an extensive clinical pipeline that often drives headline volatility. We outline the intraday drivers, financials, technical signals and a Meyka AI model forecast for IHL.AX stock.